IBDEI33F ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49390,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,49390,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,49391,0)
 ;;=N18.3^^187^2448^16
 ;;^UTILITY(U,$J,358.3,49391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49391,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,49391,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,49391,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,49392,0)
 ;;=N18.4^^187^2448^17
 ;;^UTILITY(U,$J,358.3,49392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49392,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,49392,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,49392,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,49393,0)
 ;;=N18.5^^187^2448^18
 ;;^UTILITY(U,$J,358.3,49393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49393,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,49393,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,49393,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,49394,0)
 ;;=N18.6^^187^2448^22
 ;;^UTILITY(U,$J,358.3,49394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49394,1,3,0)
 ;;=3^End Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,49394,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,49394,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,49395,0)
 ;;=J96.11^^187^2448^19
 ;;^UTILITY(U,$J,358.3,49395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49395,1,3,0)
 ;;=3^Chronic Respiratory Failure w/ Hypoxia
 ;;^UTILITY(U,$J,358.3,49395,1,4,0)
 ;;=4^J96.11
 ;;^UTILITY(U,$J,358.3,49395,2)
 ;;=^5008351
 ;;^UTILITY(U,$J,358.3,49396,0)
 ;;=J44.9^^187^2448^12
 ;;^UTILITY(U,$J,358.3,49396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49396,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,49396,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,49396,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,49397,0)
 ;;=E44.0^^187^2448^29
 ;;^UTILITY(U,$J,358.3,49397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49397,1,3,0)
 ;;=3^Moderate Protein-Calorie Malnutrition
 ;;^UTILITY(U,$J,358.3,49397,1,4,0)
 ;;=4^E44.0
 ;;^UTILITY(U,$J,358.3,49397,2)
 ;;=^5002787
 ;;^UTILITY(U,$J,358.3,49398,0)
 ;;=E43.^^187^2448^30
 ;;^UTILITY(U,$J,358.3,49398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49398,1,3,0)
 ;;=3^Severe Protein-Calorie Malnutrition
 ;;^UTILITY(U,$J,358.3,49398,1,4,0)
 ;;=4^E43.
 ;;^UTILITY(U,$J,358.3,49398,2)
 ;;=^5002786
 ;;^UTILITY(U,$J,358.3,49399,0)
 ;;=R64.^^187^2448^13
 ;;^UTILITY(U,$J,358.3,49399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49399,1,3,0)
 ;;=3^Cachexia
 ;;^UTILITY(U,$J,358.3,49399,1,4,0)
 ;;=4^R64.
 ;;^UTILITY(U,$J,358.3,49399,2)
 ;;=^17920
 ;;^UTILITY(U,$J,358.3,49400,0)
 ;;=I10.^^187^2448^23
 ;;^UTILITY(U,$J,358.3,49400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49400,1,3,0)
 ;;=3^Essential (Primary) Hypertension
 ;;^UTILITY(U,$J,358.3,49400,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,49400,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,49401,0)
 ;;=I25.10^^187^2448^11
 ;;^UTILITY(U,$J,358.3,49401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49401,1,3,0)
 ;;=3^CAD w/o Angina Pectoris
 ;;^UTILITY(U,$J,358.3,49401,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,49401,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,49402,0)
 ;;=E78.2^^187^2448^28
 ;;^UTILITY(U,$J,358.3,49402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49402,1,3,0)
 ;;=3^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,49402,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,49402,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,49403,0)
 ;;=I48.0^^187^2448^8
